Stockscreener 앱 받기
152.88
1.28%
-1.975
전일 마감가:
$154.85
열려 있는:
$154.99
하루 거래량:
719.82K
Relative Volume:
0.28
시가총액:
$43.49B
수익:
$21.92B
순이익/손실:
$1.76B
주가수익비율:
24.97
EPS:
6.1223
순현금흐름:
$2.63B
1주 성능:
-3.58%
1개월 성능:
-1.96%
6개월 성능:
-17.74%
1년 성능:
-25.23%
1일 변동 폭
$152.74
$155.38
1주일 범위
$152.74
$159.61
52주 변동 폭
$152.74
$213.08
벡톤 디킨슨 Stock (BDX) Company Profile
명칭
Becton Dickinson Co
전화
(201) 847-6800
주소
ONE BECTON DR, FRANKLIN LAKES
Compare BDX vs ISRG, MDLN, ALC, RMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BDX
Becton Dickinson Co
|
152.88 | 44.05B | 21.92B | 1.76B | 2.63B | 6.1223 |
ISRG
Intuitive Surgical Inc
|
479.96 | 169.58B | 10.58B | 3.00B | 2.83B | 8.2437 |
MDLN
Medline Inc
|
44.96 | 39.09B | 28.43B | 1.16B | 1.26B | 1.4457 |
ALC
Alcon Inc
|
75.61 | 36.98B | 10.40B | 980.00M | 1.61B | 1.9749 |
RMD
Resmed Inc
|
218.94 | 31.98B | 5.40B | 1.49B | 1.78B | 10.12 |
벡톤 디킨슨 Stock (BDX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-04-10 | 재개 | Goldman | Neutral |
| 2026-02-10 | 재개 | Barclays | Overweight |
| 2026-02-03 | 재개 | Citigroup | Buy |
| 2025-09-25 | 개시 | RBC Capital Mkts | Sector Perform |
| 2025-05-22 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2025-05-02 | 다운그레이드 | Goldman | Buy → Neutral |
| 2025-05-02 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2025-05-02 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2025-05-01 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2025-05-01 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2025-05-01 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2024-10-01 | 업그레이드 | Citigroup | Neutral → Buy |
| 2024-05-30 | 개시 | Goldman | Buy |
| 2023-07-24 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2023-05-30 | 재개 | Morgan Stanley | Overweight |
| 2023-05-05 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2023-04-12 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2023-01-03 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2022-12-12 | 업그레이드 | Citigroup | Sell → Neutral |
| 2022-07-11 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2022-06-24 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2022-03-18 | 재개 | Raymond James | Mkt Perform |
| 2022-03-02 | 재개 | BofA Securities | Neutral |
| 2021-12-08 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2021-08-06 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2021-05-25 | 개시 | Barclays | Equal Weight |
| 2020-12-15 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2020-12-15 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2020-07-09 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2020-06-01 | 재개 | Goldman | Buy |
| 2020-03-05 | 개시 | Citigroup | Neutral |
| 2020-02-07 | 다운그레이드 | Cowen | Outperform → Market Perform |
| 2020-02-07 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-02-07 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2020-02-06 | 다운그레이드 | Cowen | Outperform → Market Perform |
| 2020-01-08 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2019-05-13 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2018-12-07 | 개시 | Deutsche Bank | Buy |
| 2018-10-16 | 개시 | Barclays | Equal Weight |
| 2018-06-21 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2018-04-10 | 업그레이드 | Citigroup | Neutral → Buy |
| 2018-01-19 | 재개 | BofA/Merrill | Buy |
| 2018-01-05 | 업그레이드 | Citigroup | Sell → Neutral |
| 2018-01-05 | 개시 | KeyBanc Capital Mkts | Overweight |
| 2018-01-03 | 개시 | Evercore ISI | Outperform |
| 2017-12-29 | 재확인 | Deutsche Bank | Buy |
모두보기
벡톤 디킨슨 주식(BDX)의 최신 뉴스
Becton Dickinson & Co. stock underperforms Tuesday when compared to competitors - MarketWatch
Khaitan, Clifford Chance act on Becton Dickinson’s global spin-off of its biosciences and diagnostic solut.. - ETLegalWorld.com
Becton Dickinson and Co stock (US0758871091): Is its medtech diversification strong enough for stead - AD HOC NEWS
Deals tracker: Community Health Systems adds surgery centers - Modern Healthcare
What You Need to Know Ahead of Becton, Dickinson and Company's Earnings Release - Barchart.com
Becton, Dickinson and Company (BDX) Stock Analysis: A Look at Its 20.77% Potential Upside - DirectorsTalk Interviews
Lobbying Update: $60,000 of BECTON DICKINSON AND COMPANY lobbying was just disclosed - Quiver Quantitative
Becton Dickinson Stock Offers Stability and Dividends for Investors - HarianBasis.co
RBC Capital Lowers Becton Dickinson Price Target to $175 - HarianBasis.co
KANAWHA CAPITAL MANAGEMENT LLC's Becton Dickinson & Co(BDX) Holding History - GuruFocus
Becton Dickinson & Co stock (US0758871091): Why Google Discover visibility now matters more for medt - AD HOC NEWS
Slocum Gordon & Co LLP Makes New $1.94 Million Investment in Becton, Dickinson and Company $BDX - MarketBeat
KBC Group NV Has $14.85 Million Stock Holdings in Becton, Dickinson and Company $BDX - MarketBeat
Becton Dickinson & Co. stock outperforms competitors on strong trading day - MarketWatch
The Healthcare Stock Built for Investors Who Prioritize Capital Preservation - The Motley Fool
Piper Sandler Maintains Becton Dickinson & Co(BDX.US) With Hold Rating, Cuts Target Price to $159 - 富途牛牛
BDX Stock Price, Quote & Chart | BECTON DICKINSON AND CO (NYSE:BDX) - ChartMill
Only one medical supplier won all 3 new HIRC awards: BD - Stock Titan
Assetmark Inc. Boosts Holdings in Becton, Dickinson and Company $BDX - MarketBeat
RBC Capital Maintains Becton Dickinson & Co(BDX.US) With Hold Rating, Cuts Target Price to $175 - 富途牛牛
Third View Private Wealth LLC Takes $4.99 Million Position in Becton, Dickinson and Company $BDX - MarketBeat
Becton, Dickinson and Company $BDX Stock Holdings Lessened by Sumitomo Mitsui Trust Group Inc. - MarketBeat
Becton, Dickinson and Company’s Bilal Muhsin on the future of Connected Care - Gulf Business
Becton Dickinson And Co: A $5.3 Billion Quarter Signals Limited Growth Momentum - Smartkarma
Massachusetts Financial Services Co. MA Has $1.84 Billion Holdings in Becton, Dickinson and Company $BDX - MarketBeat
Goldman Sachs Maintains Becton Dickinson & Co(BDX.US) With Hold Rating, Cuts Target Price to $167 - 富途牛牛
Becton, Dickinson and Company (BD) 8-K Filing April 2026 – Company Details, Registered Securities, and Contact Information - Minichart
Becton, Dickinson and Company (BDX) Announces Executive Retireme - GuruFocus
Rick Byrd to Retire from BD - Finviz
Becton Dickinson & Co. stock outperforms competitors despite losses on the day - MarketWatch
Richard E. Byrd to Retire as President of Interventional at Becton Dickinson - TradingView
After 25 years at BD, a top medical device executive will retire - Stock Titan
Becton, Dickinson and Company (BDX) Stock Price, News, Quote & History - Yahoo! Finance Canada
For Women Managing Nighttime Incontinence, Better Sleep and Comfort Start with BD PureWick Urine Collection System - Finviz
OFI Invest Asset Management Grows Position in Becton, Dickinson and Company $BDX - MarketBeat
Barclays Maintains Becton Dickinson & Co(BDX.US) With Buy Rating, Maintains Target Price $202 - 富途牛牛
Becton Dickinson & Co. stock rises Wednesday, still underperforms market - MarketWatch
Becton Dickinson (BDX) Pursues CE Mark for Liverty TIPS Stent Gr - GuruFocus
BD Delivers Next-Generation TIPS Innovation to Advance Portal Hypertension Care Across the European Union - Finviz
BD Delivers Next‑Generation TIPS Innovation to Advance Portal Hypertension Care Across the European Union - PR Newswire UK
Citi Maintains Becton Dickinson & Co(BDX.US) With Buy Rating, Maintains Target Price $198 - 富途牛牛
Asio Capital LLC Invests $3.28 Million in Becton, Dickinson and Company $BDX - MarketBeat
Becton Dickinson and Company Launches HemoSphere Stream Module - marketscreener.com
BofA Securities Maintains Becton Dickinson & Co(BDX.US) With Hold Rating, Maintains Target Price $221 - 富途牛牛
Becton, Dickinson and Company (BDX) stock price, news, quote and history - Yahoo Finance UK
When Every Beat Matters, BD Helps Clinicians Eliminate Blind Spots with Continuous, Noninvasive Blood Pressure Insight - Finviz
BD Launches HemoSphere Stream Module for Continuous Blood Pressure Monitoring - Intellectia AI
BD Launches HemoSphere Stream™ Module for Continuous Non-Invasive Blood Pressure Monitoring - Intellectia AI
Rep. Kevin Hern Sells Becton, Dickinson and Company (NYSE:BDX) Shares - MarketBeat
BDX Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Becton, Dickinson and Company (NYSE:BDX) Given Average Rating of "Hold" by Analysts - MarketBeat
벡톤 디킨슨 (BDX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.78%
자본화:
|
볼륨(24시간):